NRx Pharmaceuticals, Inc (NASDAQ:NRXP) is among the best psychedelic stocks to buy in 2026. NRx Pharmaceuticals, Inc ...
NRx Pharmaceuticals NRXP is expected to report its fourth-quarter 2024 results soon. The Zacks Consensus Estimate for NRXP’s loss per share is pinned at 20 cents. In the absence of a marketed product, ...
Zacks Investment Research on MSN
NRx Pharmaceuticals, Inc. (NRXP) surpasses Q4 earnings estimates
NRx Pharmaceuticals, Inc. (NRXP) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of ...
Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
NRx Pharmaceuticals (NASDAQ:NRXP) stock rallied 35% Monday after its subsidiary HOPE Therapeutics announced the signing of a binding term sheet with Smith & Sauer for $25M in equity purchases to fund ...
On Match 21st NRXP announced the results of a Special Meeting of Shareholders giving the Board of Directors authority to effect a reverse stock split of all of the outstanding shares of NRXP stock in ...
On Match 21st NRXP announced the results of a Special Meeting of Shareholders giving the Board of Directors authority to effect a reverse stock split of all of the outstanding shares of NRXP stock in ...
Key highlights for the first full year of operation under the new management team include: A year-over-year reduction in operating expenses with $7.8 Million cash on hand at year end. With ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results